TY - JOUR
T1 - Standardization procedure for flow cytometry data harmonization in prospective multicenter studies
AU - PRECISESADS Flow Cytometry Study Group
AU - PRECISESADS Clinical Consortium
AU - Le Lann, Lucas
AU - Jouve, Pierre Emmanuel
AU - Alarcón-Riquelme, Marta
AU - Jamin, Christophe
AU - Pers, Jacques Olivier
AU - Alvarez, Montserrat
AU - Alvarez-Errico, Damiana
AU - Azevedo, Nancy
AU - Barbarroja, Nuria
AU - Buttgereit, Anne
AU - Cheng, Qingyu
AU - Chizzolini, Carlo
AU - Cremer, Jonathan
AU - De Groof, Aurélie
AU - De Langhe, Ellen
AU - Ducreux, Julie
AU - Dufour, Aleksandra
AU - Gerl, Velia
AU - Hernandez-Fuentes, Maria
AU - Khodadadi, Laleh
AU - Kniesch, Katja
AU - Li, Tianlu
AU - Lopez-Pedrera, Chary
AU - Makowska, Zuzanna
AU - Marañón, Concepción
AU - Muchmore, Brian
AU - Neves, Esmeralda
AU - Rouvière, Bénédicte
AU - Simon, Quentin
AU - Trombetta, Elena
AU - Varela, Nieves
AU - Witte, Torsten
AU - Aguilar-Quesada, Rocío
AU - Aguirre-Zamorano, Maria Angeles
AU - Almeida, Isabel
AU - Baerlecken, Niklas
AU - Balog, Attila
AU - Belz, Doreen
AU - Beretta, Lorenzo
AU - Alonso, Ricardo Blanco
AU - Bocskai, Márta
AU - Brandão, Mariana
AU - Rubio, José Luis Callejas
AU - Campar, Ana
AU - Castro-Villegas, Maria Carmen
AU - Cervera, Ricardo
AU - Collantes, Eduardo
AU - Cornec, Divi
AU - Martínez, Alfonso Corrales
AU - Meroni, Pier Luigi
PY - 2020/12/1
Y1 - 2020/12/1
N2 - One of the most challenging objective for clinical cytometry in prospective multicenter immunomonitoring trials is to compare frequencies, absolute numbers of leukocyte populations and further the mean fluorescence intensities of cell markers, especially when the data are generated from different instruments. Here, we describe an innovative standardization workflow to compare all data to carry out any large-scale, prospective multicentric flow cytometry analysis whatever the duration, the number or type of instruments required for the realization of such projects.
AB - One of the most challenging objective for clinical cytometry in prospective multicenter immunomonitoring trials is to compare frequencies, absolute numbers of leukocyte populations and further the mean fluorescence intensities of cell markers, especially when the data are generated from different instruments. Here, we describe an innovative standardization workflow to compare all data to carry out any large-scale, prospective multicentric flow cytometry analysis whatever the duration, the number or type of instruments required for the realization of such projects.
UR - http://www.scopus.com/inward/record.url?scp=85087992934&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087992934&partnerID=8YFLogxK
U2 - 10.1038/s41598-020-68468-3
DO - 10.1038/s41598-020-68468-3
M3 - Article
C2 - 32665668
AN - SCOPUS:85087992934
VL - 10
JO - Scientific Reports
JF - Scientific Reports
SN - 2045-2322
IS - 1
M1 - 11567
ER -